GSK
GSK | NYSE
$49.51
+$0.83 (+1.71%)
At close: Oct 30, 2026, 4:00 PM ET
$49.26
-$0.25 (-0.50%)
Pre-market:
Nov 2, 2026, 7:56 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 12.91 | 21.45 | 12.09 | 3.90 | 11.89 | 9.35 |
PEG Ratio | 0.10 | -0.44 | -0.18 | 0.02 | -2.45 | 0.41 |
PS Ratio | 2.26 | 1.76 | 1.97 | 1.99 | 2.11 | 2.20 |
PB Ratio | 4.51 | 4.03 | 3.51 | 5.52 | 2.56 | 2.69 |
P/FCF Ratio | 12.66 | 15.42 | 9.55 | 8.66 | 9.85 | 8.25 |
P/OCF Ratio | 10.32 | 8.41 | 7.57 | 7.17 | 6.56 | 6.35 |
OCF/S Ratio | 21.87 | 20.89 | 26.02 | 27.83 | 32.20 | 34.66 |
Debt / Equity Ratio | 1.08 | 1.24 | 1.35 | 1.98 | 1.61 | 1.86 |
Quick Ratio | 0.54 | 0.52 | 0.62 | 0.68 | 0.54 | 0.64 |
Current Ratio | 0.82 | 0.78 | 0.88 | 0.91 | 0.79 | 0.91 |
Asset Turnover | 0.54 | 0.53 | 0.40 | 0.49 | 0.23 | 0.22 |
Interest Coverage | 12.14 | 6.11 | 8.70 | 7.52 | 5.56 | 6.70 |
Return on Equity | 34.96% | 18.84% | 28.96% | 141.12% | 21.50% | 28.83% |
Return on Assets | 9.37% | 4.33% | 6.55% | 24.87% | 4.09% | 5.23% |
Return on Invested Capital | 16.61% | 8.51% | 11.37% | 13.62% | 5.32% | 6.96% |
Dividend Yield | 3.40% | 4.44% | 4.67% | 7.30% | 7.67% | 7.42% |
Payout Ratio | 43.87% | 94.91% | 56.68% | 28.55% | 91.20% | 69.18% |
FCF Payout Ratio | 43.06% | 75.71% | 44.64% | 63.24% | 80.71% | 64.57% |
Gross Profit Margin | 72.40% | 71.16% | 71.76% | 67.42% | 66.95% | 67.44% |
Net Profit Margin | 17.50% | 8.21% | 16.25% | 51% | 17.76% | 23.61% |
Pretax Profit Margin | 22.66% | 11.08% | 19.99% | 19.19% | 14.57% | 21.23% |
Operating Profit Margin | 25.52% | 12.82% | 22.24% | 21.94% | 17.64% | 24.55% |
FCF Margin | 17.83% | 11.38% | 20.63% | 23.03% | 21.45% | 26.67% |
EBITDA Margin | 31.84% | 21.25% | 29.95% | 29.33% | 26.26% | 33.12% |
Add to Watchlist
Select watchlists to add or remove GSK